The majority of orphan drugs are subject to utilization controls in Medicare Part D plans. The use of utilization controls varies by certain drug characteristics.
Farah Yehia, PhD
Advertisement
Articles by Farah Yehia, PhD
Advertisement
Latest Updated Articles
- Predictors of Orphan Drug Coverage Restrictions in Medicare Part D
Published: September 8th 2020 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
A "One-Two Punch" to Innovation? The Most Favored Nation Order and Broader US Drug Pricing Reform
2
White House to Announce Second Drug Pricing Deal as AstraZeneca Joins TrumpRx
3
Telemedicine Boosts Quality of Life, Inhaler Technique for Severe COPD
4
Bispecific Antibodies in Multiple Myeloma Are Moving From Clinical Trials to Community Practice
5
